Hypha Labs, Inc.
FUNI
$0.03
$0.00-7.87%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -3.94% | -12.65% | 7.87% | 1,748.87% | 518.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.94% | -12.65% | 7.87% | 1,748.87% | 518.45% |
| Operating Income | 3.94% | 12.65% | -7.87% | -1,748.87% | -518.45% |
| Income Before Tax | -16.87% | 22.97% | -7,922.50% | -850.07% | -184.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.83% | 20.50% | -1,031.92% | -850.07% | -177.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -100.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.83% | 20.50% | -372.18% | -983.64% | -278.48% |
| EBIT | 3.94% | 12.65% | -7.87% | -1,748.87% | -518.45% |
| EBITDA | 4.42% | 13.33% | -- | -- | -1,556.44% |
| EPS Basic | 2.56% | 37.88% | -288.46% | -735.29% | -230.00% |
| Normalized Basic EPS | 14.81% | 29.73% | 29.55% | -560.00% | -125.00% |
| EPS Diluted | 2.56% | 59.00% | -484.62% | -735.29% | -230.00% |
| Normalized Diluted EPS | 14.81% | 29.73% | 29.55% | -560.00% | -125.00% |
| Average Basic Shares Outstanding | 24.92% | 27.12% | 42.35% | 43.08% | 36.09% |
| Average Diluted Shares Outstanding | 24.92% | 27.12% | 42.35% | 43.08% | 36.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |